Liste über die Bewertung des regulatorischen Bedarfs

Liste über die Bewertung des regulatorischen Bedarfs

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 03 Mai 2024. Database contains 5017 unique substances/entries.
Filter the list
Foreseen regulatory need:
Date of intention:
Date of assessment:
Latest update:

The List does not contain any Substances.
 
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
SVHC
10-Jul-2015
Details
covering any of its individual anti- and syn-isomers or any combination thereof
-
-
United Kingdom
Bioaccumulation
Persistence
Concluded
SVHC
10-Aug-2018
Details
204-661-8
123-91-1
Germany
Bioaccumulation
Persistence
Concluded
SVHC
Restriction
17-Jun-2020
Details
214-317-9
1120-71-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
06-Feb-2015
Details
214-946-9
1222-05-5
ECHA
Under development
CLH
SVHC
Pending action
04-Mai-2023
Details
271-094-0
68515-51-5
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
SVHC
13-Jan-2015
Details
253-692-3
37853-59-1
Spain
Bioaccumulation
Endocrine disruption
Persistence
Concluded
SVHC
Restriction
21-Jul-2022
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
SVHC
10-Jul-2015
Details
253-242-6
36861-47-9
Denmark
Endocrine disruption
Concluded
SVHC
04-Dez-2020
Details
948-069-4
-
ECHA
Under development
CoRAP
CLH
SVHC
04-Mai-2023
Details
931-296-8
97862-59-4
ECHA
Under development
RMOA
16-Nov-2018
Details
931-333-8
-
ECHA
Under development
RMOA
16-Nov-2018
Details
931-513-6
-
ECHA
Under development
RMOA
16-Nov-2018
Details
700-230-8
3160-86-9
ECHA
Under development
RMOA
13-Jan-2023
Details
224-292-6
4292-10-8
ECHA
Under development
RMOA
16-Nov-2018
Details
205-251-1
136-53-8
ECHA
Under development
Restriction
24-Nov-2023
Details
Electrolytic solution from electrolysis of zinc sulfate consisting primarily of zinc sulfate, manganese oxides and sulfuric acid.
273-723-4
69012-24-4
ECHA
Under development
Restriction
02-Apr-2024
Details
show/hide
Sodium undecafluorohexanoate EC / List no: 220-881-7 | CAS no: 2923-26-4
-
-
Germany
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Restriction
07-Dez-2017
Details
237-159-2
13674-87-8
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
228-150-4
6145-73-9
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
204-118-5
115-96-8
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
237-158-7
13674-84-5
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
201-117-1
78-43-3
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
239-487-1
15468-32-3
Netherlands
STOT RE
Concluded
Restriction
Other legislation
10-Mär-2023
Details
206-203-2
307-55-1
Germany
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Restriction
07-Mär-2017
Details
238-009-9
14166-21-3
ECHA
Under development
Restriction
19-Feb-2021
Details
206-108-6
301-10-0
ECHA
Under development
Restriction
24-Mai-2023
Details
272-388-1
68815-67-8
ECHA
Under development
Restriction
31-Mär-2023
Details
203-726-8
109-99-9
Germany
Consumer use
Concluded
CLH
Restriction
20-Sep-2022
Details
246-563-8
25013-16-5
France
Endocrine disruption
Concluded
Restriction
30-Jan-2015
Details
-
-
France
Carcinogenic
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Restriction
12-Nov-2019
Details
Substances manufactured in form of fibres with length ≥ 5 µm, a diameter < 3 µm and aspect ratio ≥ 3:1 as well as fibres released from substances, mixtures or articles during their life cycle due to mechanical effects (e.g. breaking/splicing), chemical processes (e.g. oxidation/ageing) or physical conditions (e.g. heat), excluding asbestos
-
-
Germany
Carcinogenic
Concluded
Restriction
30-Mai-2023
Details
219-536-3
2457-02-5
ECHA
Under development
Restriction
24-Nov-2023
Details
243-283-8
19766-89-3
ECHA
Under development
Restriction
24-Nov-2023
Details
Substance formed during processing of liquid steel or during production of iron castings. Consists primarily of fused silicates and trace elements as oxides as well as trace of alloying elements.
294-409-3
91722-09-7
ECHA
Under development
Restriction
29-Nov-2023
Details
The fused substance formed by the action of a flux upon the gangue of iron-bearing materials charged to a steelmaking furnace and upon the oxidized impurities in the steel produced. Depending upon the particular steelmaking operation, the slag is composed primarily of sulfur and oxides of aluminum, calcium, iron, magnesium, manganese, phosphorus, and silicon.
266-004-1
65996-71-6
ECHA
Under development
Restriction
29-Nov-2023
Details
By-product of the manufacture of silicomanganese alloy containing oxides of aluminum, calcium, magnesium, manganese and silicon.
273-733-9
69012-33-5
ECHA
Under development
Restriction
29-Nov-2023
Details
Substance formed by processing of chiefly oxidic material with lead and zinc content in a rotating furnace. Consists primarily of Al2O3, CaO, Fe, FeO and SiO2 with other nonferrous compounds as well as carbon.
297-907-9
93763-87-2
ECHA
Under development
Restriction
29-Nov-2023
Details
Slag formed as the feed progresses through the blast furnace in lead smelting. Consists primarily of metallic elements and oxides of calcium, magnesium and silicon.
273-825-9
69029-84-1
ECHA
Under development
Restriction
29-Nov-2023
Details
The fused substance formed by the action of a flux upon the gangue of the iron-bearing materials charged to a blast furnace and upon the oxidized impurities in the iron produced. Depending upon the particular blast furnace operation, the slag is composed primarily of sulfur and oxides of aluminum, calcium, magnesium, and silicon.
266-002-0
65996-69-2
ECHA
Under development
Restriction
29-Nov-2023
Details
By-product of the manufacture of ferromanganese alloy containing primarily oxides of aluminum, manganese and silicon.
273-728-1
69012-28-8
ECHA
Under development
Restriction
29-Nov-2023
Details
701-265-1
-
ECHA
Under development
Restriction
29-Nov-2023
Details
show/hide
skin sensitising substances EC / List no: - | CAS no: -
-
-
Sweden
Skin sensitiser
Concluded
Restriction
02-Feb-2017
Details
946-132-0
-
ECHA
Under development
Restriction
13-Jul-2022
Details
807-935-0
1244733-77-4
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
428-050-2
-
ECHA
Under development
Restriction
18-Feb-2022
Details
911-815-4
-
ECHA
Under development
CLH
Restriction
26-Jul-2022
Details
903-161-3
-
ECHA
Under development
Restriction
31-Mär-2023
Details
946-797-7
-
ECHA
Under development
Restriction
13-Jul-2022
Details
906-378-1
-
ECHA
Under development
Restriction
13-Jul-2022
Details

Export search results to: